Table 1 Study period details
Control | Run-in | Intervention | |
|---|---|---|---|
Start date | 01–01-17 | 01–05-18 | 01–10-18 |
End date | 01–05-18 | 01–10-18 | 29–02-20 |
Study days, n | 485 | 153 | 516 |
Patients, n | 969 | 958 | 904 |
Person years, n | 1286 | 401 | 1277 |
Sex | |||
Female, % | 70 | 70 | 69 |
Control | Run-in | Intervention | |
|---|---|---|---|
Start date | 01–01-17 | 01–05-18 | 01–10-18 |
End date | 01–05-18 | 01–10-18 | 29–02-20 |
Study days, n | 485 | 153 | 516 |
Patients, n | 969 | 958 | 904 |
Person years, n | 1286 | 401 | 1277 |
Sex | |||
Female, % | 70 | 70 | 69 |